The International Stroke Trial (IST): A randomised trial of aspirin, subcutaneous heparin, both, or neither among 19 435 patients with acute ischaemic stroke

Ripley, R; Richards, S; Wilberforce, S; Chen, ZM; vanGijn, J; Harrison, M; Wilhelmsen, L; Warlow, C; Anderson, S; Bowie, A; Boyle, J; Brownlie, A; Charlton, D; Cranswick, G; Day, L; Dennis, M; Dorman, P; Fraser, H; Kaye, M; Lindley, R; Liu, M; MacDonald, C; McCrindle, I; Middleton, G; Perry, D; Scoltock, V; Smith, B; Taylor, H; Waddell, F; Sandercock, P; Collins, R; Counsell, C; Farrell, B; Peto, R; Slattery, J; Wardlaw, J; Crowther, J; Heineman, J; Knight, S; Radley, A

Tarih

1997

Yazar

Ripley, R

Richards, S

Wilberforce, S

Chen, ZM

vanGijn, J

Harrison, M

Wilhelmsen, L

Warlow, C

Anderson, S

Bowie, A

Boyle, J

Brownlie, A

Charlton, D

Cranswick, G

Day, L

Dennis, M

Dorman, P

Fraser, H

Kaye, M

Lindley, R

Liu, M

MacDonald, C

McCrindle, I

Middleton, G

Perry, D

Scoltock, V

Smith, B

Taylor, H

Waddell, F

Sandercock, P

Collins, R

Counsell, C

Farrell, B

Peto, R

Slattery, J

Wardlaw, J

Crowther, J

Heineman, J

Knight, S

Radley, A

Üst veri

Tüm öğe kaydını göster

Özet

Background Only a few small trials have compared antithrombotic therapy (antiplatelet or anticoagulant agents) versus control in acute ischaemic stroke, and none has been large enough to provide reliable evidence on safety or efficacy.

Bağlantı

http://hdl.handle.net/20.500.12627/52685
https://doi.org/10.1016/s0140-6736(97)04011-7

Koleksiyonlar

Makale [92796]